Acropectorovertebral dysplasia
diseaseOn this page
Also known as Acropectorovertebral dysplasia F formACRPVF syndrome
Summary
Acropectorovertebral dysplasia (MONDO:0007058) is a disease. A subtype of thoracic malformation — broader associated-gene and molecular evidence is on the parent page (see Disease family below).
At a glance
- Prevalence: <1 / 1 000 000 (Worldwide) [Orphanet-validated]
- Phenotypes (HPO): 12
Clinical features
Epidemiology
Prevalence records
2 prevalence record(s), Orphanet:
| Type | Class | Value | Geography | Validation |
|---|---|---|---|---|
| Cases/families | 30 | Worldwide | Validated | |
| Point prevalence | <1 / 1 000 000 | Worldwide | Validated |
Signs & symptoms
Clinical features (HPO)
12 HPO clinical features (Orphanet curated; top 12 by frequency):
| HPO ID | Term | Frequency |
|---|---|---|
| HP:0000767 | Pectus excavatum | Very frequent (80-99%) |
| HP:0001199 | Triphalangeal thumb | Very frequent (80-99%) |
| HP:0005048 | Synostosis of carpal bones | Very frequent (80-99%) |
| HP:0006101 | Finger syndactyly | Very frequent (80-99%) |
| HP:0008368 | Tarsal synostosis | Very frequent (80-99%) |
| HP:0009882 | Short distal phalanx of finger | Very frequent (80-99%) |
| HP:0011304 | Broad thumb | Very frequent (80-99%) |
| HP:0001256 | Intellectual disability, mild | Frequent (30-79%) |
| HP:0002414 | Spina bifida | Frequent (30-79%) |
| HP:0000175 | Cleft palate | Occasional (5-29%) |
| HP:0002705 | High, narrow palate | Occasional (5-29%) |
| HP:0100490 | Camptodactyly of finger | Occasional (5-29%) |
Identifiers
Disease identifiers
| Field | Value |
|---|---|
| Canonical name | Acropectorovertebral dysplasia |
| Mondo ID | MONDO:0007058 |
| MeSH | C566319 |
| OMIM | 102510 |
| Orphanet | 957 |
| ICD-11 | 1013313909 |
| SNOMED CT | 720457000 |
| UMLS | C1863307 |
| MedGen | 400262 |
| GARD | 0000512 |
| Is cancer (heuristic) | no |
Also known as: Acropectorovertebral dysplasia · Acropectorovertebral dysplasia F form · ACRPV · F syndrome
Disease family
This is a subtype of thoracic malformation. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.
Classification path: disease › human disease › disease by body system or component › respiratory system disorder › respiratory or thoracic malformation › thoracic malformation › Acropectorovertebral dysplasia
Related subtypes (14): congenitally short costocoracoid ligament, Sprengel deformity, thoracolaryngopelvic dysplasia, fetal akinesia deformation sequence, lethal congenital contracture syndrome 1, orofaciodigital syndrome IV, thoracic dysplasia-hydrocephalus syndrome, thoracomelic dysplasia, Matthew-Wood syndrome, NEK9-related lethal skeletal dysplasia, short rib-polydactyly syndrome, shoulder and thorax deformity-congenital heart disease syndrome, sternal cleft, ossification anomalies-psychomotor developmental delay syndrome
Genetics & variants
GWAS landscape
No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.
Variant details and genetic-evidence tiers
No tiered GWAS variants or ClinVar records for this disease.
Genes & proteins
No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).
Function
No pathway enrichment — requires an associated-gene cohort.
Therapeutics
No druggable-target or therapeutic data for this disease’s cohort.
Clinical trials & evidence
Clinical trials
Clinical trials: 0.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.